Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China

References

• Kumar SK, Rajkumar V, Kyle RA, et al. Multiple myeloma. Nat Rev Dis Primers. 2017;3:17046. doi:10.1038/nrdp.2017.46
   PubMed Web of Science ®Google Scholar
• Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538–e548. doi:10.1016/S1470-2045(14)70442-5
   PubMed Web of Science ®Google Scholar
• Kyle RA, Therneau TM, Rajkumar SV, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354:1362–1369. doi:10.1056/NEJMoa054494
   PubMed Web of Science ®Google Scholar
• Landgren O, Graubard BI, Kumar S, et al. Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey. Blood Cancer J. 2017;7:e618. doi:10.1038/bcj.2017.97
   PubMed Web of Science ®Google Scholar
• Cowan AJ, Allen C, Barac A, et al. Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016. JAMA Oncol. 2018;4:1221–1227. doi:10.1001/jamaoncol.2018.2128
   PubMed Web of Science ®Google Scholar
• Sigurdardottir EE, Turesson I, Lund SH, et al. The role of diagnosis and clinical follow-up of monoclonal gammopathy of undetermined significance on survival in multiple myeloma. JAMA Oncol. 2015;1:168–174. doi:10.1001/jamaoncol.2015.23
   PubMed Web of Science ®Google Scholar
• Kyle RA, Larson DR, Therneau TM, et al. Long-Term follow-up of monoclonal gammopathy of undetermined significance. N Engl J Med. 2018;378:241–249. doi:10.1056/NEJMoa1709974
   PubMed Web of Science ®Google Scholar
• Murray DL, Seningen JL, Dispenzieri A, et al. Laboratory persistence and clinical progression of small monoclonal abnormalities. Am J Clin Pathol. 2012;138:609–613. doi:10.1309/AJCPT6OWWMHITA1Y
   PubMed Web of Science ®Google Scholar
• Keren DF, Bocsi G, Billman BL, et al. Laboratory detection and initial diagnosis of monoclonal gammopathies. Arch Pathol Lab Med. 2022;146:575–590. doi:10.5858/arpa.2020-0794-CP
   PubMedGoogle Scholar
• Willrich MA, Katzmann JA. Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias. Clin Chem Lab Med. 2016;54:907–919.
   PubMed Web of Science ®Google Scholar
• Wu SP, Minter A, Costello R, et al. MGUS prevalence in an ethnically Chinese population in Hong Kong. Blood. 2013;121:2363–2364. doi:10.1182/blood-2012-11-466011
   PubMed Web of Science ®Google Scholar
• Li J, Wen L, Tang J, et al. Prevalence of monoclonal gammopathy of undetermined significance in an apparently healthy yixing population in mainland China. Acta Haematol. 2017;137:17–19. doi:10.1159/000450881
   PubMed Web of Science ®Google Scholar
• Han JH, Wang JN, Zhang YL, et al. Prevalence of monoclonal gammopathy of undetermined significance in a large population with annual medical check-ups in China. Blood Cancer J. 2020;10:34. doi:10.1038/s41408-020-0303-8
   PubMed Web of Science ®Google Scholar
• Ma L, Xu S, Qu J, et al. Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study. Hematol Oncol. 2019;37:75–79. doi:10.1002/hon.2548
   PubMed Web of Science ®Google Scholar
• Katzmann JA, Clark RJ, Abraham RS, et al. Serum reference intervals and diagnostic ranges for free κ and free λ immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem. 2002;48:1437–1444. doi:10.1093/clinchem/48.9.1437
   PubMed Web of Science ®Google Scholar
• Landgren O, Graubard BI, Katzmann JA, et al. Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey. Leukemia. 2014;28:1537–1542. doi:10.1038/leu.2014.34
   PubMed Web of Science ®Google Scholar
• Eisele L, Dürig J, Hüttmann A, et al. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany. Ann Hematol. 2012;91:243–248. doi:10.1007/s00277-011-1293-1
   PubMed Web of Science ®Google Scholar
• Lecluse Y, Comby E, Mariotte D, et al. Prevalence of monoclonal gammopathy of undetermined significance (MGUS) among farmers involved in open field farming and/or cattle breading in France. Leuk Lymphoma. 2016;57:1727–1730. doi:10.3109/10428194.2015.1113277
   PubMed Web of Science ®Google Scholar
• Kyle RA, Durie BG, Rajkumar SV, et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia. 2010;24:1121–1127. doi:10.1038/leu.2010.60
   PubMed Web of Science ®Google Scholar
• Watanaboonyongcharoen P, Nakorn TN, Rojnuckarin P, et al. Prevalence of monoclonal gammopathy of undetermined significance in Thailand. Int J Hematol. 2012;95:176–181. doi:10.1007/s12185-011-0995-4
   PubMed Web of Science ®Google Scholar
• Lee YG, Bang SM, Lee JO, et al. Five-Year follow-up study of monoclonal gammopathy of undetermined significance in a Korean elderly urban cohort. Cancer Res Treat. 2015;47:215–220. doi:10.4143/crt.2013.262
   PubMed Web of Science ®Google Scholar
• Park HK, Lee KR, Kim YJ, et al. Prevalence of monoclonal gammopathy of undetermined significance in an elderly urban Korean population. Am J Hematol. 2011;86:752–755. doi:10.1002/ajh.22095
   PubMed Web of Science ®Google Scholar
• Iwanaga M, Tagawa M, Tsukasaki K, et al. Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan. Mayo Clin Proc. 2007;82:1474–1479. doi:10.1016/S0025-6196(11)61090-2
   PubMed Web of Science ®Google Scholar
• Cicero KI, Joffe M, Patel M, et al. Prevalence of monoclonal gammopathy of undetermined significance in black South African Men. Cancer Epidemiol Biomarkers Prev. 2022;31:2192–2198. doi:10.1158/1055-9965.EPI-22-0525
   PubMed Web of Science ®Google Scholar
• van de Donk NW, Mutis T, Poddighe PJ, et al. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Int J Lab Hematol. 2016;38:110–122. doi:10.1111/ijlh.12504
   PubMed Web of Science ®Google Scholar
• Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78:21–33. doi:10.4065/78.1.21
   PubMed Web of Science ®Google Scholar
• Murray DL, Ryu E, Snyder MR, et al. Quantitation of serum monoclonal proteins: relationship between agarose gel electrophoresis and immunonephelometry. Clin Chem. 2009;55:1523–1529. doi:10.1373/clinchem.2009.124461
   PubMed Web of Science ®Google Scholar
• Katzmann JA, Snyder MR, Rajkumar SV, et al. Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies. Clin Chem. 2011;57:1687–1692. doi:10.1373/clinchem.2011.171314
   PubMed Web of Science ®Google Scholar
• Barnidge DR, Dasari S, Botz CM, et al. Using mass spectrometry to monitor monoclonal immunoglobulins in patients with a monoclonal gammopathy. J Proteome Res. 2014;13:1419–1427. doi:10.1021/pr400985k
   PubMed Web of Science ®Google Scholar
• Kohlhagen MC, Barnidge DR, Mills JR, et al. Screening method for M-proteins in serum using nanobody enrichment coupled to MALDI-TOF mass spectrometry. Clin Chem. 2016;62:1345–1352. doi:10.1373/clinchem.2015.253781
   PubMed Web of Science ®Google Scholar
• Katzmann JA, Kyle RA, Benson J, et al. Screening panels for detection of monoclonal gammopathies. Clin Chem. 2009;55:1517–1522. doi:10.1373/clinchem.2009.126664
   PubMed Web of Science ®Google Scholar
• Bertrand KA, Zirpoli G, Niharika Pillalamarri B, et al. Prevalence of monoclonal gammopathy of undetermined significance in US black women. Am J Hematol. 2022;97:E341–E343. doi:10.1002/ajh.26638
   PubMed Web of Science ®Google Scholar